open access
Factor XIII Val34Leu polymorphism in patients with cardiac syndrome X
open access
Abstract
Background: The aim of the study was to examine the frequency of factor XIII polymorphism among patients with cardiac syndrome X (CSX).
Methods: This study was designed as a cross-sectional and observational study. Forty-eight female patients with CSX and 36 controls matched by age, gender, diabetes, and hypertension were studied. CSX was defined as typical chest pain during rest or effort, abnormal test result for exercise ECG, and presence of angiographically normal epicardial coronary arteries after ruling out inducible spasm. Factor XIII gene polymorphism was investigated by using CVD Strip Assay (ViennaLab Diagnostic GmbH) commercial kit.
Results: The frequency of factor XIII (Val/Leu + Leu/Leu) mutation was significantly higher in patients with CSX (43%) than in controls (19%) (p = 0.02). Frequency of the Leu allele was significantly higher in the patient group (23.5% vs. 11.1%, p = 0.04). Factor XIII (Val/Leu + Leu/Leu) mutation (p = 0.01, OR = 3.42; 95% CI 1.22–9.58) and smoking (p = 0.04, OR = 3.33, 95% CI 1.05–10.58) were identified as independent predictors of the disease in multivariate regression analysis.
Conclusions: This study indicates that there is an evidence for association between factor XIII Val34Leu polymorphism and CSX.
Abstract
Background: The aim of the study was to examine the frequency of factor XIII polymorphism among patients with cardiac syndrome X (CSX).
Methods: This study was designed as a cross-sectional and observational study. Forty-eight female patients with CSX and 36 controls matched by age, gender, diabetes, and hypertension were studied. CSX was defined as typical chest pain during rest or effort, abnormal test result for exercise ECG, and presence of angiographically normal epicardial coronary arteries after ruling out inducible spasm. Factor XIII gene polymorphism was investigated by using CVD Strip Assay (ViennaLab Diagnostic GmbH) commercial kit.
Results: The frequency of factor XIII (Val/Leu + Leu/Leu) mutation was significantly higher in patients with CSX (43%) than in controls (19%) (p = 0.02). Frequency of the Leu allele was significantly higher in the patient group (23.5% vs. 11.1%, p = 0.04). Factor XIII (Val/Leu + Leu/Leu) mutation (p = 0.01, OR = 3.42; 95% CI 1.22–9.58) and smoking (p = 0.04, OR = 3.33, 95% CI 1.05–10.58) were identified as independent predictors of the disease in multivariate regression analysis.
Conclusions: This study indicates that there is an evidence for association between factor XIII Val34Leu polymorphism and CSX.
Keywords
cardiac syndrome X, factor XIII polymorphism
About this articleTitle
Factor XIII Val34Leu polymorphism in patients with cardiac syndrome X
Journal
Issue
Pages
6-10
Published online
2013-04-26
Page views
1969
Article views/downloads
1697
DOI
10.5603/CJ.a2013.0046
Bibliographic record
Cardiol J 2014;21(1):6-10.
Keywords
cardiac syndrome X
factor XIII polymorphism
Authors
Gamze Babur Güler
Ulaankhuu Batgerel
Ekrem Güler
Oğuz Karaca
Çetin Geçmen
Hacı Murat Güneş
Hicaz Zencirkıran Aguş
Ali Metin Esen
Mehmet Muhsin Türkmen
